Suzanne K. Swan, MD; William M. Bennett, MD
This content is PDF only. Please click on the PDF icon to access.
To the Editor: Acyclovir (9- [ (2-hydroxyethoxy)methyl] guanine), an acyclic purine nuclease, is the treatment of choice for herpes zoster and varicella in the immunocompromised host. Adverse effects attributed to acyclovir therapy include nausea, vomiting, rash, phlebitis, myelosuppression, and decreased renal function. Neurotoxicity, manifested by vertigo, obtundation, headache, confusion, seizures, and tremor, has been linked to intravenous acyclovir therapy. To our knowledge, neurotoxicity has not been reported after oral acyclovir therapy. We present a case of neurotoxicity following orally administered acyclovir in a patient with end-stage renal disease.
A 76-year-old woman receiving chronic hemodialysis presented with a 2-day history of
Swan SK, Bennett WM. Oral Acyclovir and Neurotoxicity. Ann Intern Med. 1989;111:188. doi: 10.7326/0003-4819-111-2-188_1
Download citation file:
Published: Ann Intern Med. 1989;111(2):188.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use